UK tests five-day breast cancer radiotherapy
The UK has launched a clinical trial testing if breast cancer radiotherapy can be cut from three weeks to five days, potentially saving patients 10 hospita Read More: https://punchng.com/uk-tests-five-day-breast-cancer-radiotherapy/
Over 1,000 individuals are participating in a government-funded clinical trial exploring the possibility of reducing breast cancer radiotherapy from three weeks to five days. This shorter treatment course, combined with an additional targeted dose called a boost, aims to prevent cancer from returning. The FAST-Forward Boost trial is being conducted in 39 hospitals throughout the United Kingdom.
The UK Department of Health and Social Care revealed the progress, emphasizing its role in enhancing cancer treatment and patient support. Led by the Institute of Cancer Research, London, and funded by the National Institute for Health and Care Research, the trial aims to recruit 4,830 participants by 2028, with follow-up for five years.
Results are expected in 2033. If successful, this shorter treatment schedule could decrease patients' travel expenses and time away from work and family, freeing up healthcare resources for more people. Health and Social Care Secretary Yvette Cooper highlighted how the UK is leveraging its research capabilities to bring about significant improvements in cancer treatment.
The trial demonstrates the commitment to using world-class research to transform cancer care for patients.
Written by urgent.news from Punch Nigeria's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
